Wednesday’s agreement by the Food and Drug Administration and Juul was to suspend their court battle while the government reviews Juul’s electronic cigarettes. This agreement is one day after FDA placed a hold to its original order banning Juul products from the marketplace. FDA stated that Juul’s application deserved “additional scrutiny.”
According to the filing by the federal court, Juul can still sell its e-cigarettes.
“With the FDA’s administrative stay now in effect, we can continue to offer our products for adult smokers while we pursue their internal review process,” a spokesperson for the company said in a statement.
Juul was ordered by the FDA to remove its products from market on June 23. Juul requested that a federal appeals court temporarily block the ban by government officials.
Juul will have thirty days to file a request for a stay if the FDA decides to reimpose the ban.
Companies must prove that e-cigarettes are good for public health in order to remain on the market. This means that e-cigarettes must be proven to have a positive effect on public health.
FDA regulators recently approved a few e-cigarettes made by some of Juul’s main rivals, R.J. Reynolds or NJOY. Industry players and anti-vaping advocates waited eagerly for an FDA decision regarding Juul’s products. They are currently the most popular e-cigarettes in America.
Initial FDA statements stated that Juul’s application raised significant questions about regulators, including about its chemical composition of vaping formulations. Juul claimed it had provided enough information and data for all the issues that were raised.
